Entering text into the input field will update the search result below

Eli Lilly slashes insulin prices by 70%, places $35 monthly out-of-pocket cap

Mar. 01, 2023 9:00 AM ETEli Lilly and Company (LLY)SNYBy: Jonathan Block, SA News Editor10 Comments

Insulin syringe pen injector humalog kwik-pen

dml5050/iStock via Getty Images

  • Eli Lilly (NYSE:LLY) is cutting the prices of its insulin drugs by 70% and introducing a program that will cap out-of-pocket expenses at $35 per month.
  • The reductions impact Insulin Lispro, Humalog (insulin lispro injection), and Humulin (insulin human).

Recommended For You

Comments (10)

Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

The government forced Eli Lilly's hand in this and I believe due to Lilly's decision most Americans will end up getting their insulin made in China or India as a generic drug which is dangerous. Yes Lilly will cut the price but eventually you will see it will become a generic coming from India and elsewhere.
miriam64 profile picture
Always liked pharmaceuticals. When a company as this slices their prices they will be lauded, other companies will follow and do the same.. the share prices will do up and diabetics will not have to Sacrifice so much! Miriam64
Martin Keck profile picture
@miriam64 why will profit and share price go up, when you lower prices?
01 Mar. 2023
All it took was the California State government to start manufacturing it's own insulin for other manufactures to cut prices. Good work California.
Investor since ‘73 profile picture
Proud to be a long term holder of LLY, it’s been a great investment and the best is yet to come. This is a great move, a welcome relief for millions of Americans and their diabetes/obesity drug will be the holy grail, making Viagra look like a little niche drug. Then there’s the Alzheimer’s drug that worked so well they had to stop the trial to expand it because so many subjects responded so quickly they stopped taking it before the end date. A new, larger study will unleash the dam and the profits will flow like a river.

LLY and MP are my two highest confidence picks for the year. And years to come.
@Investor since ‘73 Lilly makes money but usually after it makes the dough, it has to give up the drug that made them rich. Remember Darvocet-N , Bextra, and than Zyprexa the anti psychotic and bi-polar drug that made everyone gain so much weight they became diabetic. Yes Lilly, made money, but in terms of decency, average rating
bill h illify profile picture
You are welcome.
Good for them and good for all those who struggle to pay for such a necessary drug
Stefan Redlich profile picture
Good move
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.